Greg Walden
The Public Record
Greg Walden is a former U.S. Representative from Oregon, serving in the House from 1999 to 2021. A member of the Republican Party, he represented Oregon's 2nd congressional district. During his tenure, Walden was known for his work on issues related to healthcare, telecommunications, and energy policy. He played a significant role in the passage of the 21st Century Cures Act, which aimed to accelerate medical product development and bring new innovations to patients more quickly.
To do this effectively, we need to look to see where we can update our laws and regulatory policies for the 21st Century.
It shouldn't be overlooked that LNG exports also strengthen our diplomatic hand when dealing with countries like Russia that like to use energy resources as a weapon.
Easterseals appreciates the bipartisan support in Congress for HVRP and the current legislative efforts to help accomplish our HVRP authorization and funding goals.
I'm looking forward to hearing from the witnesses today about how their companies think about the best ways to utilize IoT.
Thank you, Mr. Chairman, for holding this hearing to give us a chance to look at ways to modernize the Superfund cleanup program.
I want to thank Economic Opportunity Subcommittee Member Kathleen Rice of New York for her work with Representative Greg Walden.
There is bipartisan agreement that we want, and need, to see American manufacturing succeed.
How can we best harness the Department's enormous scientific, technical, and world-class capabilities to enhance America's national, economic, and energy security?
The importance of DOE's role in serving the national and public interest has increased.
I appreciate that you know how this committee operates, and look forward to accomplishing much together.
I would also like to recognize Administrator Klotz's long service to our country.
this is a really important hearing for the committee, and it is a goal of this committee to begin the process to modernize the Department of Energy
I thank my friend and colleague, the chairman of the House Appropriations Committee, Mr. Frelinghuysen, for his incredible and tenacious work to bring us this legislation. By the way, all 12 appropriations bills have already been passed by…
We are well past the time in which we should have had this done. The Energy and Commerce Committee has acted. The U.S. House of Representatives has acted. The Senate Finance Committee has acted. But the full Senate has yet to do so. I know…
I appreciate your comments and those of Mr. Green's about the full set of issues before us and the overwhelming desire by our constituents that we dive deep into the whole drug chain.
I thank my colleagues on both sides of the aisle for their great work on this: Mr. Rush from Illinois and, of course, the former chairman of the Energy and Commerce Committee, my friend, Mr. Upton, and our other committee members who put…
We must find workable solutions that incentivize competition in the pharmaceutical marketplace, reward value, and encourage the development of affordable and high quality drugs.
The United States' abundant energy resources are a major contributor to our Nation's continued economic growth and job creation.
We need to have a work group. We need to have some sort of rump group to address this issue.
This problem demands a bipartisan, thoughtful process that includes the full spectrum of stakeholders.
I look forward to receiving an update from our witnesses today on how they are dealing with different requirements.
The American people deserve a Government that removes barriers to innovation and growth and avoids unnecessarily driving up costs for consumers.





